Company: SONM
Filing Date: 2025-11-24
Form Type: PREM14A
Source: 0001493152-25-024848
Chunk: 355

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-11-24
Form: PREM14A
Chunk 355
---
 31, 2024. One additional customer accounts for 15% of accounts receivable, net, at December 31, 2023.

| F-39 |

NOTE 6—Convertible Preferred Stock and Stockholders’ Equity

On November 2, 2018, the Company amended and restated its previous certificate of incorporation and adjusted its authorized capital stock (par value of $0.001) to consist of 100,000,000 shares of common stock and 5,000,000 shares of preferred stock. Each outstanding share of common stock entitles the holder to one vote on each matter properly submitted to the stockholders of the Company for vote. As of December 31, 2024, no shares of preferred stock have been issued.

The following table, as adjusted for the Reverse Stock Split, shows shares of common stock reserved as of:

Schedule of Common Stock Reserved

|                                                     |     |         2024 |           |     | 2023 |         |
|                                                     |     | December 31, |           |     |      |         |
|                                                     |     |         2024 |           |     | 2023 |         |
| Shares subject to options to purchase common stock  |     |              |   755,494 |     |      | 514,674 |
| Unvested restricted stock units                     |     |              |    67,962 |     |      |  68,185 |
| Shares subject to warrants to purchase common stock |     |              |   350,000 |     |      |       1 |
| Total                                               |     |              | 1,173,456 |     |      | 582,860 |

NOTE 7—Stockholders’ Equity

Equity Financing

On April 29, 2024, the Company closed on a capital investment of 350,000 shares of common stock and warrants, as adjusted for the Reverse Stock Split, with a single investor for an aggregate purchase price of $3,850. In connection with the closing, the Company incurred approximately $66 in issuance costs, which was offset against the proceeds.

Each warrant has an exercise price of $11.00 per share, as adjusted for the Reverse Stock Split, is immediately exercisable, will expire in five years from the date of issuance, and is subject to customary adjustments for certain transactions affecting the Company’s capitalization. The warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by